Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

634 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Epigenetic modifications and human disease.
Portela A, Esteller M. Portela A, et al. Among authors: esteller m. Nat Biotechnol. 2010 Oct;28(10):1057-68. doi: 10.1038/nbt.1685. Nat Biotechnol. 2010. PMID: 20944598 Review.
Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome.
Esteller M, Avizienyte E, Corn PG, Lothe RA, Baylin SB, Aaltonen LA, Herman JG. Esteller M, et al. Oncogene. 2000 Jan 6;19(1):164-8. doi: 10.1038/sj.onc.1203227. Oncogene. 2000. PMID: 10644993
Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes.
Esteller M. Esteller M. Eur J Cancer. 2000 Dec;36(18):2294-300. doi: 10.1016/s0959-8049(00)00303-8. Eur J Cancer. 2000. PMID: 11094302 Review.
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours.
Esteller M, Herman JG. Esteller M, et al. J Pathol. 2002 Jan;196(1):1-7. doi: 10.1002/path.1024. J Pathol. 2002. PMID: 11748635 Review.
The impact of chromatin in human cancer: linking DNA methylation to gene silencing.
Ballestar E, Esteller M. Ballestar E, et al. Among authors: esteller m. Carcinogenesis. 2002 Jul;23(7):1103-9. doi: 10.1093/carcin/23.7.1103. Carcinogenesis. 2002. PMID: 12117766 Review.
Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors.
Paz MF, Avila S, Fraga MF, Pollan M, Capella G, Peinado MA, Sanchez-Cespedes M, Herman JG, Esteller M. Paz MF, et al. Among authors: esteller m. Cancer Res. 2002 Aug 1;62(15):4519-24. Cancer Res. 2002. PMID: 12154064
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M. Esteller M. Oncogene. 2002 Aug 12;21(35):5427-40. doi: 10.1038/sj.onc.1205600. Oncogene. 2002. PMID: 12154405 Review.
Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors.
Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M, Watkins DN, Herman JG, Mankowski JL, Baylin SB. Chen WY, et al. Among authors: esteller m. Nat Genet. 2003 Feb;33(2):197-202. doi: 10.1038/ng1077. Epub 2003 Jan 21. Nat Genet. 2003. PMID: 12539045
DNA demethylating agents and chromatin-remodelling drugs: which, how and why?
Villar-Garea A, Esteller M. Villar-Garea A, et al. Among authors: esteller m. Curr Drug Metab. 2003 Feb;4(1):11-31. doi: 10.2174/1389200033336757. Curr Drug Metab. 2003. PMID: 12570743 Review.
A systematic profile of DNA methylation in human cancer cell lines.
Paz MF, Fraga MF, Avila S, Guo M, Pollan M, Herman JG, Esteller M. Paz MF, et al. Among authors: esteller m. Cancer Res. 2003 Mar 1;63(5):1114-21. Cancer Res. 2003. PMID: 12615730
634 results
Jump to page
Feedback